Approval · Notice of Compliance 26810 · 2021
ALTRENO: Notice of Compliance 26810
Issued October 8, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26810
- Date
- October 8, 2021
- Company
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Administrative: Product Name Change To convert the Product Monograph to 2020 format
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALTRENO | Not yet assigned | — |
Medicinal ingredients
- TRETINOIN 0.05 PER